Clinical Trial Update: Durability of Virologic Response and/or Viral Resistance Patterns in Participants With Chronic Hepatitis C Who Have Been Previously Treated With Grazoprevir (MK-5172) (MK-5172-017)

View source ↗

Summary

Clinical trial update reporting durability of virologic response and resistance patterns in patients with chronic hepatitis C previously treated with grazoprevi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Grazoprevir (grazoprevir)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Hepatitis C | Status: COMPLETED | Results posted: 2022-06-06